These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 12798838)

  • 21. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction.
    Sun SX; Ye X; Lee KY; Dupclay L; Plauschinat C
    Clin Ther; 2008; 30 Pt 2():2217-27. PubMed ID: 19281916
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-terminal pro-B-type natriuretic peptide-guided, intensive patient management in addition to multidisciplinary care in chronic heart failure a 3-arm, prospective, randomized pilot study.
    Berger R; Moertl D; Peter S; Ahmadi R; Huelsmann M; Yamuti S; Wagner B; Pacher R
    J Am Coll Cardiol; 2010 Feb; 55(7):645-53. PubMed ID: 20170790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of home versus clinic-based management of chronic heart failure: the WHICH? (Which Heart Failure Intervention Is Most Cost-Effective & Consumer Friendly in Reducing Hospital Care) multicenter, randomized trial.
    Stewart S; Carrington MJ; Marwick TH; Davidson PM; Macdonald P; Horowitz JD; Krum H; Newton PJ; Reid C; Chan YK; Scuffham PA
    J Am Coll Cardiol; 2012 Oct; 60(14):1239-48. PubMed ID: 23017533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Reducing hospital stay and costs in heart failure. The proper diuretic makes the difference].
    MMW Fortschr Med; 2003 Jan; 145(3-4):58. PubMed ID: 12619239
    [No Abstract]   [Full Text] [Related]  

  • 25. Economic burden of heart failure: a summary of recent literature.
    Lee WC; Chavez YE; Baker T; Luce BR
    Heart Lung; 2004; 33(6):362-71. PubMed ID: 15597290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness and cost-utility of a structured collaborative disease management in the Interdisciplinary Network for Heart Failure (INH) study.
    Neumann A; Mostardt S; Biermann J; Gelbrich G; Goehler A; Geisler BP; Siebert U; Störk S; Ertl G; Angerrmann CE; Wasem J
    Clin Res Cardiol; 2015 Apr; 104(4):304-9. PubMed ID: 25403774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early Postdischarge STOP-HF-Clinic Reduces 30-day Readmissions in Old and Frail Patients With Heart Failure.
    Pacho C; Domingo M; Núñez R; Lupón J; Moliner P; de Antonio M; González B; Santesmases J; Vela E; Tor J; Bayes-Genis A
    Rev Esp Cardiol (Engl Ed); 2017 Aug; 70(8):631-638. PubMed ID: 28215922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [New multidisciplinary heart failure care program (six-month preliminary observation)].
    Wierzchowiecki M; Poprawski K; Nowicka A; Kandziora M; Piatkowska A; Jankowiak M; Michałowicz B; Stawski W; Kaszuba D
    Pol Merkur Lekarski; 2006 Dec; 21(126):511-5. PubMed ID: 17405287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness of specialized multidisciplinary heart failure clinics in Ontario, Canada.
    Wijeysundera HC; Machado M; Wang X; Van Der Velde G; Sikich N; Witteman W; Tu JV; Lee DS; Goodman SG; Petrella R; O'Flaherty M; Capewell S; Krahn M
    Value Health; 2010 Dec; 13(8):915-21. PubMed ID: 21091970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Torasemide: a pharmacoeconomic review of its use in chronic heart failure.
    Young M; Plosker GL
    Pharmacoeconomics; 2001; 19(6):679-703. PubMed ID: 11456215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Economic implications of extended-release metoprolol succinate for heart failure in the MERIT-HF trial: a US perspective of the MERIT-HF trial.
    Caro JJ; Migliaccio-Walle K; O'Brien JA; Nova W; Kim J; Hauch O; Hillson E; Wedel H; Hjalmarson A; Gottlieb S; Deedwania PC; Wikstrand J;
    J Card Fail; 2005 Dec; 11(9):647-56. PubMed ID: 16360958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment practices in heart failure with preserved left ventricular ejection fraction: a prospective observational study.
    Peltier M; Houpe D; Cohen-Solal A; Béguin M; Levy F; Tribouilloy C
    Int J Cardiol; 2007 Jun; 118(3):363-9. PubMed ID: 17049391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The CARE-HF study (CArdiac REsynchronisation in Heart Failure study): rationale, design and end-points.
    Cleland JG; Daubert JC; Erdmann E; Freemantle N; Gras D; Kappenberger L; Klein W; Tavazzi L;
    Eur J Heart Fail; 2001 Aug; 3(4):481-9. PubMed ID: 11511435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Health care costs of heart failure: results from a randomised study of patient education.
    Linné AB; Liedholm H; Jendteg S; Israelsson B
    Eur J Heart Fail; 2000 Sep; 2(3):291-7. PubMed ID: 10938491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Long-term diuretic treatment in heart failure: are there differences between furosemide and torasemide?].
    Spannheimer A; Müller K; Falkenstein P; Reitberger U; Gutzwiller F; Follath F
    Praxis (Bern 1994); 2002 Sep; 91(37):1467-75. PubMed ID: 12360682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Understanding the economic burden of heart failure in China: impact on disease management and resource utilization.
    Huang J; Yin H; Zhang M; Ni Q; Xuan J
    J Med Econ; 2017 May; 20(5):549-553. PubMed ID: 28286996
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The costs of heart failure in Poland from the public payer's perspective. Polish programme assessing diagnostic procedures, treatment and costs in patients with heart failure in randomly selected outpatient clinics and hospitals at different levels of care: POLKARD.
    Czech M; Opolski G; Zdrojewski T; Dubiel JS; Wizner B; Bolisęga D; Fedyk-Łukasik M; Grodzicki T
    Kardiol Pol; 2013; 71(3):224-32. PubMed ID: 23575775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors influencing the length of hospital stay of patients with heart failure.
    Wright SP; Verouhis D; Gamble G; Swedberg K; Sharpe N; Doughty RN
    Eur J Heart Fail; 2003 Mar; 5(2):201-9. PubMed ID: 12644013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and socio-economic burden of heart failure in an aging society of South Korea.
    Lee H; Oh SH; Cho H; Cho HJ; Kang HY
    BMC Cardiovasc Disord; 2016 Nov; 16(1):215. PubMed ID: 27832754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two-year outcome of a prospective, controlled study of a disease management programme for elderly patients with heart failure.
    Del Sindaco D; Pulignano G; Minardi G; Apostoli A; Guerrieri L; Rotoloni M; Petri G; Fabrizi L; Caroselli A; Venusti R; Chiantera A; Giulivi A; Giovannini E; Leggio F
    J Cardiovasc Med (Hagerstown); 2007 May; 8(5):324-9. PubMed ID: 17443097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.